Pankti Reid, MD, MPH, is a highly skilled rheumatologist whose practice primarily focuses on evaluation and management of immune-related adverse events (irAEs) where cancer patients experience autoimmune conditions as a side effect of their cancer treatment. Dr. Reid also provides general rheumatology care and has expertise with the following conditions:

• Checkpoint inhibitor toxicities (immune-related adverse events)
• Inflammatory Arthritis
• Inflammatory Myositis
• Vasculitis
• Lupus
• Scleroderma
• Sicca Syndrome
• Polymyalgia Rheumatica

In an effort to improve care for her patients, Dr. Reid established a robust immune-related adverse event (irAE) clinical infrastructure that includes a clinic, an electronic referral system and an interdisciplinary clinical consortium. Additionally, she is developing an irAE curriculum aimed at improving training in this new area of medicine for internal medicine residents and oncology and rheumatology fellows.

Dr. Reid has also led multiple clinical trials studying the use of rheumatic medications for COVID-19 hyperinflammation.

Her research has been published in several respected, peer-reviewed journals, including the Journal of the American Medical Association and Journal of Immunotherapy for Cancer.